MANDOLESI, Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 786
EU - Europa 320
AS - Asia 123
AF - Africa 30
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.261
Nazione #
US - Stati Uniti d'America 786
IT - Italia 78
UA - Ucraina 54
CN - Cina 52
SE - Svezia 47
SG - Singapore 44
IE - Irlanda 42
DE - Germania 27
CI - Costa d'Avorio 19
FR - Francia 19
DK - Danimarca 18
MA - Marocco 11
GB - Regno Unito 10
TR - Turchia 10
FI - Finlandia 9
KR - Corea 9
IN - India 6
BE - Belgio 4
NL - Olanda 3
RO - Romania 3
AT - Austria 2
RS - Serbia 2
BR - Brasile 1
CZ - Repubblica Ceca 1
EU - Europa 1
HR - Croazia 1
JP - Giappone 1
TH - Thailandia 1
Totale 1.261
Città #
Chandler 130
Ashburn 67
Fairfield 65
Jacksonville 59
Boardman 49
Woodbridge 43
Dublin 42
New York 34
Seattle 32
Wilmington 32
Des Moines 27
Ann Arbor 25
Houston 24
Cambridge 23
Abidjan 19
Ancona 19
Singapore 18
Lawrence 15
Princeton 15
San Mateo 14
Turin 12
Beijing 9
Centro 7
San Diego 6
Los Angeles 5
Brussels 4
Pune 4
Strasbourg 4
Washington 4
Dallas 3
Fermignano 3
Guangzhou 3
Jiaxing 3
Wuhan 3
Wuxi 3
Amsterdam 2
Appignano 2
Falconara Marittima 2
Helsinki 2
Izmir 2
London 2
Marche 2
Modena 2
Shanghai 2
Slobozia 2
Vienna 2
Bangkok 1
Belgrade 1
Catania 1
Changsha 1
Chiswick 1
Chizhou 1
Fayetteville 1
Frankfurt am Main 1
Fuzhou 1
Hounslow 1
Hwang Chow 1
Jesi 1
Manaus 1
Munich 1
Nanchang 1
New Bedfont 1
Newark 1
Norwalk 1
Olomouc 1
Porto 1
Redwood City 1
Shenzhen 1
Yiwu 1
Zibo 1
Totale 871
Nome #
Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy 118
Are liver nested stromal epithelial tumors always low aggressive? 116
Liver transplantation for metastatic wild-type gastrointestinal stromal tumor in the era of molecular targeted therapies: report of a first case. 93
CANCER STEM CELL GENETIC PROFILE AS PREDICTOR OF RELAPSE IN RADICALLY RESECTED COLORECTAL CANCER 82
Bilateral squamous cell carcinoma of the feet associated with HPV16 infection. 81
A germline missense mutation in exon 3 of the MSH2 gene in a Lynch syndrome family: correlation with phenotype and localization assay 81
Radiological response and inflammation scores predict tumour recurrence in patients treated with transarterial chemoembolization before liver transplantation. 81
VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study 79
Roc-king onwards: Intraepithelial lymphocyte counts, distribution & role in coeliac disease mucosal interpretation 78
KRAS: To be or not to be targeted? Biologic and computational analyses in pancreatic adenocarcinoma 77
Seminoma Retroperitoneal Relapse 23 Years After Surgery 77
Prospective study of a molecular selection profile for RAS wild type colorectal cancer patients receiving irinotecan-cetuximab 75
An observational retrospective analysis of the main metastatic site and corresponding locoregional treatment as a prognostic factor in metastatic gastric cancer 71
Mycophenolate mofetil-induced colitis in a patient with systemic sclerosis 67
Lynch syndrome-associated lung cancer: pitfalls of an immunotherapy-based treatment strategy in an unusual tumor type 51
CROHN'S DISEASE AND EARLY ISOLATED ORAL PRESENTATION 38
Retrospective Cohort Study of Caveolin-1 Expression as Prognostic Factor in Unresectable Locally Advanced or Metastatic Pancreatic Cancer Patients 30
A rare case of solitary plasmacytoma mimicking submucosal lesion of ascending colon: a case report and literature review 5
Totale 1.300
Categoria #
all - tutte 7.519
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.519


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202073 0 0 0 0 13 3 12 3 15 6 4 17
2020/2021282 21 20 33 0 32 14 17 16 25 53 43 8
2021/2022129 2 29 6 0 2 10 5 7 8 12 17 31
2022/2023353 23 43 20 26 31 59 0 21 71 2 50 7
2023/2024209 25 6 21 23 24 63 1 6 0 5 2 33
2024/2025132 56 31 9 16 20 0 0 0 0 0 0 0
Totale 1.300